BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8478220)

  • 1. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
    Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
    J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
    Ishikawa A
    Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R; Diaz LK; Laskin WB; Pins MR
    J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
    Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
    Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
    Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
    Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.
    Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ
    Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of incidental carcinoma of the prostate. II. Nuclear DNA analysis].
    Fujita T; Akino H; Kanimoto Y; Okada K; Shiraishi T; Nakakuki K
    Hinyokika Kiyo; 1991 Sep; 37(9):1009-16. PubMed ID: 1785407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer.
    Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM
    Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
    Menke-Pluymers MB; Hop WC; Mulder AH; Tilanus HW
    Hepatogastroenterology; 1995; 42(6):786-8. PubMed ID: 8847023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry.
    Berner A; Danielsen HE; Juul NO; Juul ME; Pettersen EO; Reith A; Nesland JM; Fosså SD
    Anal Cell Pathol; 1993 Nov; 5(6):339-52. PubMed ID: 8305330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.
    Lundberg S; Carstensen J; Rundquist I
    Cancer Res; 1987 Apr; 47(7):1973-7. PubMed ID: 3815387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum.
    Robey-Cafferty SS; el-Naggar AK; Grignon DJ; Cleary KR; Ro JY
    Mod Pathol; 1990 May; 3(3):261-6. PubMed ID: 2362936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.